scholarly journals Adjuvant trastuzumab emtansine in human epidermal growth factor receptor 2-positive breast cancer: Take-home points from the KATHERINE trial

2020 ◽  
Vol 33 (3) ◽  
pp. 158
Author(s):  
Atul Batra ◽  
Ilavarasi Vanidassane ◽  
RamavathDevendra Naik ◽  
Vinod Sharma ◽  
Sachin Khurana
Keyword(s):  
Breast Cancer ◽  
Epidermal Growth Factor Receptor ◽  
Growth Factor ◽  
Epidermal Growth Factor ◽  
Growth Factor Receptor ◽  
Trastuzumab Emtansine ◽  
Adjuvant Trastuzumab ◽  
Human Epidermal Growth Factor ◽  
Epidermal Growth ◽  
Positive Breast Cancer
Sign in / Sign up

Export Citation Format

Share Document